{"id":"W4402559856","doi":"10.1016/j.annonc.2024.08.824","title":"763P Re-VOLVE: Phase II trial in women with ovarian cancer progressing post-PARP-inhibitor with treatment adapted to real-time assessment of evolving genomic resistance","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; PARP inhibitor; Ovarian cancer; Oncology; Internal medicine; Poly ADP ribose polymerase; Gynecology; Cancer; Genetics; DNA; Polymerase; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007898386,0.001229487,0.001472529,0.0003600481,0.0002616369,0.001129873,0.0006474159,0.001221941,0.01156367],"category_scores_gemma":[0.001023605,0.000444897,0.001282661,0.000337697,0.0008860155,0.0007633774,0.0004950761,0.00395751,0.001940236],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008446843,"about_ca_system_score_gemma":0.001164936,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001308538,"about_ca_topic_score_gemma":0.00378314,"domain_scores_codex":[0.9997514,0.00008390503,0.000008370119,0.00007135209,0.00002804961,0.00005700812],"domain_scores_gemma":[0.9997293,0.00005479317,0.00004171654,0.00002921533,0.00001762578,0.0001272744],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5547192,0.01907518,0.008667561,0.001473121,0.001736481,0.0001747212,0.0003242522,0.009940214,0.02983398,0.001332947,0.01881352,0.3539088],"study_design_scores_gemma":[0.6662998,0.2862933,0.01923813,0.0001763544,0.0008054269,0.0004386571,0.0001753057,0.005084868,0.004328985,0.001402146,0.01566215,0.00009481396],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9674361,0.004852333,0.00200775,0.003641054,0.0007139854,0.004287879,0.00545546,0.0008659433,0.01073936],"genre_scores_gemma":[0.9634985,0.00325678,0.005382925,0.003512879,0.0002647618,0.003928907,0.007421108,0.000172759,0.01256147],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01156367,"threshold_uncertainty_score":0.03868437,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05025327819796144,"score_gpt":0.4148274938004348,"score_spread":0.3645742156024733,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}